Ranbaxy gets US nod for Augmentin syrup version
Just two months after Ranbaxy's US-launch of the generic version of Augmentin in a tablet form - Ranbaxy today announced that it had received the green signal from US regulatory authorities to launch
Just two months after Ranbaxy's US-launch of the generic version of Augmentin in a tablet form - Ranbaxy today announced that it had received the green signal from US regulatory authorities to launch